Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03982576 · ClinicalTrials.gov registry record · NA
Innovations to Prevent Relapse Among Low-income African American Smokers
A NA study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT03982576: Completed NA study, sponsored by Case Comprehensive Cancer Center.
NCT03982576 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03982576, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this research is to study a relapse prevention program for adult former smokers in Northeast Ohio. The study will also look at how different people respond to the program. Participants asked to take part in this study because they contacted the team for help remaining tobacco-free or otherwise expressed interest in the program. The study includes completing surveys and receiving text messages to help stay tobacco free.
Primary Outcome
Biochemically verified point prevalence abstinence (ppa) confirmed by breath carbon monoxide and saliva cotinine will confirm self-reported cessation at each follow-up.
Interventions
- OTHER Nicotine replacement therapy (NRT)
- BEHAVIORAL SmokefreeTXT
- BEHAVIORAL Path2Quit
- BEHAVIORAL Relapse prevention program
- BEHAVIORAL CS-CBT intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2019-10-31 |
| Phase | NA |
What the finished NCT03982576 record still lists
NCT03982576 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which Nicotine replacement therapy (NRT) is the first listed.
NCT03982576 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03982576 about?
NCT03982576 is a clinical study titled "Innovations to Prevent Relapse Among Low-income African American Smokers". The purpose of this research is to study a relapse prevention program for adult former smokers in Northeast Ohio. The study will also look at how different people respond to the program. Participants asked to take part in this study because they contacted the team for help remaining tobacco-free or ...
What is the current status of trial NCT03982576?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2019-01-01. Estimated completion is 2019-10-31.
What interventions are being tested in trial NCT03982576?
The interventions under investigation include: Nicotine replacement therapy (NRT) (OTHER), SmokefreeTXT (BEHAVIORAL), Path2Quit (BEHAVIORAL), Relapse prevention program (BEHAVIORAL), CS-CBT intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03982576?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03982576's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI